All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

← First12345...804Next →

hiv & aids news selected from other sources

  • New and experimental HIV treatments
    Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV
    Business Wire | 8 hours ago

    Proven efficacy and durability of darunavir combined with the improved renal laboratory and bone mineral density profile of emtricitabine/tenofovir alafenamide as compared to emtricitabine/tenofovir disoproxil fumarate into one single tablet

  • Policy
    The HIV response in Ukraine: at a crossroads
    The Lancet (free registration required) | 8 hours ago

    The Ukrainian Government is looking to shoulder more of the burden of the response to the HIV epidemic in the midst of a complicated health-care overhaul.

  • Finance and funding
    Kaiser/UNAIDS Study Finds Donor Government Funding for HIV Declined by 7% in 2016, Falling to Lowest Level Since 2010
    Kaiser Family Foundation | 8 hours ago

    Donor government funding to support HIV efforts in low- and middle-income countries decreased by US$511 million from US$7.5 billion in 2015 to US$7 billion in 2016, finds a new report from the Kaiser Family Foundation and the Joint United Nations Programme on HIV/AIDS (UNAIDS). This marks the second successive year of declines, and is the lowest level since 2010.

  • Finance and funding
    Declining Funding and Shrinking Donor Base Imperils Continued Success of HIV Prevention
    AVAC | 10 hours ago

    A new report released today ahead of the 9th IAS Conference on HIV Science documents 2016 funding and highlights a continuing trend of flat or declining funding and its potential impact on further innovation in HIV prevention research and development (R&D).

  • Global health initiatives
    AIDS deaths are almost half of what they were in 2005 — but experts worry Trump could reverse that
    Mic | 12 hours ago

    “If the president’s budget were enacted, we would see the progress that has been gained over the last decade reversed very quickly, and all of the hard-fought gains reversed almost quicker than we achieved them,” said Mitchell Warren, executive director of HIV-prevention advocacy group AVAC.

  • Cancer
    Boys Are Being Denied A Vaccine That Prevents Cancer. Why Is This Being Allowed To Happen?
    Huffington Post | 13 hours ago

    Yesterday, a short-sighted and shameful recommendation was made not to give teenage boys the potentially life-saving Human Papilloma Virus (HPV) vaccine.

  • Resistance
    WHO urges action against HIV drug resistance threat
    World Health Organization | 20 July 2017

    WHO alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveys conducted in several countries. The Organization warns that this growing threat could undermine global progress in treating and preventing HIV infection if early and effective action is not taken.

  • Microbicides
    IPM receives multi-year award from UK government to advance technologies for women's HIV
    Eurekalert Medicine & Health | 20 July 2017

    The nonprofit International Partnership for Microbicides (IPM) announced today that it has received a £12 million (US$15.6 million) award over four years from the United Kingdom government through the Department for International Development to advance promising HIV and multipurpose prevention products that women could use to protect their sexual and reproductive health.

  • Recreational drug use
    Campaigner with drug past warns of 'chemsex' HIV link
    Medical Xpress | 20 July 2017

    The sexual health expert credited with coining the term "chemsex" told AFP that drug-laced sexual encounters are boosting HIV infections in gay communities. David Stuart, who manages the chemsex support programme at a pioneering clinic in Soho, was himself involved in drugs and escorting and contracted HIV before turning his life around after a 2005 arrest.

  • Achieving the 90-90-90 target
    The scales have tipped—UNAIDS announces 19.5 million people on life-saving treatment and AIDS-related deaths halved since 2005
    UNAIDS | 20 July 2017

    UNAIDS has released a new report showing that for the first time the scales have tipped: more than half of all people living with HIV (53%) now have access to HIV treatment and AIDS-related deaths have almost halved since 2005. In 2016, 19.5 million of the 36.7 million people living with HIV had access to treatment, and AIDS-related deaths have fallen from 1.9 million in 2005 to 1 million in 2016. Provided that scale-up continues, this progress puts the world on track to reach the global target of 30 million people on treatment by 2020.

← First12345...1335Next →

Conference news

News from the 25th International Harm Reduction Conference (HR17).

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

New EUROBulletin

Read the July edition of the Sexual Health & HIV Policy EUROBulletin.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.